In connection with the implementation of the project entitled ‘Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids’ by Biotechna SA under agreement no. 2022/ABM/06/00005 -00 for co-financing of a commercial project under the Competition for the development of targeted or personalised medicine based on medicinal products based on nucleic acids and small molecule compounds, the Contracting Authority is conducting market research on the costs of purchasing and delivering the chemical reagent 1H-Tetrazol.
In order to submit an offer, please read the detailed content of the offer provided below in the request for quotation 84/2025 and send the completed offer form and the assortment and price form.